CD9 and acute myeloid leukemia: Therefore, we focused on the patterns of expressions of 4 factors, namely, p53, MRP1, AKR1B10, and AKR1B1, and devised the Urayasu classification for AML, a prognostic classification based on the mechanisms of development of drug resistance in AML, as shown in Figure 3.